OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies
Vassilis Genoud, Denis Migliorini
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3493-3493
Open Access | Times Cited: 7
Vassilis Genoud, Denis Migliorini
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3493-3493
Open Access | Times Cited: 7
Showing 7 citing articles:
Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
Jing Zhou, Luohong Li, Minqi Jia, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 7207-7221
Open Access | Times Cited: 21
Jing Zhou, Luohong Li, Minqi Jia, et al.
Cancer Medicine (2022) Vol. 12, Iss. 6, pp. 7207-7221
Open Access | Times Cited: 21
Nanoengineered immune check point inhibitors delivery for targeted brain cancer treatment: Current status and future perspectives
Juan Liu, Yichao Wang, Zhidu Song, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116789-116789
Closed Access
Juan Liu, Yichao Wang, Zhidu Song, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116789-116789
Closed Access
Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma: What happened to the evidence?
Timothée Olivier, Denis Migliorini
Revue Neurologique (2023) Vol. 179, Iss. 5, pp. 502-505
Open Access | Times Cited: 7
Timothée Olivier, Denis Migliorini
Revue Neurologique (2023) Vol. 179, Iss. 5, pp. 502-505
Open Access | Times Cited: 7
Immune landscape-based machine-learning–assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma
Haiyan Li, Jian He, Menglong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Haiyan Li, Jian He, Menglong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Glioblastoma therapy: State of the field and future prospects
Nadia Allahyarzadeh Khiabani, Mohammad Amin Doustvandi, Darren Story, et al.
Life Sciences (2024) Vol. 359, pp. 123227-123227
Closed Access
Nadia Allahyarzadeh Khiabani, Mohammad Amin Doustvandi, Darren Story, et al.
Life Sciences (2024) Vol. 359, pp. 123227-123227
Closed Access
Exploring the combined anti-cancer effects of sodium butyrate and celastrol in glioblastoma cell lines: a novel therapeutic approach
Bahar Kartal, Farika Nur Denizler-Ebiri, Mustafa Güven, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Open Access
Bahar Kartal, Farika Nur Denizler-Ebiri, Mustafa Güven, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Open Access
Special Issue “Tumors of the Nervous System: New Insights into Signaling, Genetics and Therapeutic Targeting”
Sabrina Di Bartolomeo, Marco Segatto
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8700-8700
Open Access | Times Cited: 1
Sabrina Di Bartolomeo, Marco Segatto
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8700-8700
Open Access | Times Cited: 1
